Medical News

RSS

Researchers receive grant to improve treatment for patients with COPD

Research into improving treatment for patients with one of the UK's most common respiratory diseases has received a -810,000 funding boost.

28 Jul 2014

New wave of patients boosting hospital earnings

Earnings reports offered last week by two hospital operators offer evidence that the health law's coverage expansion is leading more patients to seek treatment.

28 Jul 2014

St. Jude Children's Research Hospital earns Secretary of Defense Employer Support Freedom Award

St. Jude Children's Research Hospital has been named one of 15 recipients of the Secretary of Defense Employer Support Freedom Award from the Employer Support of the Guard and Reserve of the Department of Defense.

28 Jul 2014

Childhood obesity linked to early puberty

A new link has been identified between obesity in childhood and the lowering of the age of puberty.

28 Jul 2014

Endoscopic resection not always best for localized, early-stage esophageal cancer: Study

A new study, published in the July, 2014, issue of the Journal of the National Cancer Institute by Northwestern Medicine- researchers, sheds new light on the risks associated with the growing popularity of endoscopic resection in the treatment of localized, early-stage esophageal cancer.

28 Jul 2014

ECRI Institute PSO selected to provide patient safety data to MCIC Vermont

ECRI Institute Patient Safety Organization has been selected to provide patient safety collection, analysis, and reporting services to MCIC Vermont, Inc. PSO, a component entity of MCIC Vermont (A Reciprocal Risk Retention Group).

28 Jul 2014

Medicare turns up heat on fraud investigations

One U.S. attorney in South Dakota says such cases will be one of the fastest-growing areas of criminal investigations, while some providers are crying foul.

28 Jul 2014

PLXNA4 gene may increase risk of developing Alzheimer's disease

Researchers from Boston University School of Medicine report variants in a new gene, PLXNA4, which may increase the risk of developing Alzheimer's disease (AD). The discovery of this novel genetic association may lead to new drug treatment options that target PLXNA4 specifically.

28 Jul 2014

Astute Medical, OCD partner to expand access to new acute kidney injury test

Astute Medical, Inc. today announced a strategic collaboration with Ortho-Clinical Diagnostics, Inc. that will expand access to a new test that assesses critically ill patients for risk of acute kidney injury (AKI), a prevalent and deadly condition.

From Ortho-Clinical Diagnostics, Inc. 28 Jul 2014

Psychemedics' Q2 revenue increases 12% to $7.7 million

Psychemedics Corporation today announced second quarter financial results for the period ended June 30, 2014. The Company also announced a quarterly dividend of $0.15 per share payable to shareholders of record as of August 7, 2014 to be paid on August 18, 2014.

28 Jul 2014

athenahealth expands strategic agreement with Henry Schein

athenahealth, Inc., a leading provider of cloud-based services for electronic health record (EHR), practice management, and care coordination, and Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners, today announced an expansion of their strategic agreement announced on May 21, 2014.

28 Jul 2014

Cardioxyl reports positive results from CXL-1427 Phase I trial for treatment of ADHF

Cardioxyl Pharmaceuticals, Inc. announced today the positive results of a clinical trial demonstrating that CXL-1427, a novel potential treatment for acute decompensated heart failure (ADHF), was well tolerated in healthy volunteers.

28 Jul 2014

Avidus acquires Truestar Health

Avidus Management Group Inc. is pleased to announce that further to its news release of July 16, 2014, it has completed the acquisition of substantially all of the assets of Truestar Health Inc., a Toronto based network-marketing company (the "Acquisition").

28 Jul 2014

Envarsus gets marketing authorization from EC for treatment of kidney and liver transplant patients

Veloxis Pharmaceuticals A/S and Chiesi Farmaceutici S.p.A. today announced that the European Commission (EC) has granted marketing authorization for Envarsus for the prevention of organ rejection in adult kidney and liver transplant patients in the European Union.

28 Jul 2014

FDA clears Lorus' LOR-253 IND application for treatment of hematologic malignancies

Lorus Therapeutics Inc. today announced that the Food and Drug Administration completed its review and cleared the company's Investigational New Drug (IND) application of LOR-253 for the treatment of hematologic malignancies including acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS), lymphomas and multiple myeloma.

28 Jul 2014

New study in recognition of World Hepatitis Day released on Life Sciences Connect

The Intellectual Property and Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today released a new study in recognition of World Hepatitis Day on Life Sciences Connect, a blog exploring the latest news and trends in Life Sciences and updates on the drug pipeline identifying multiple treatments in development that may serve as potential alternatives to Gilead's Sovaldi, currently priced in the United States at $84,000 for 12 weeks of treatment - $1000 per pill.

28 Jul 2014

First Edition: July 28, 2014

Today's headlines include reports about the deal reached by House and Senate negotiators regarding veterans' health care.

28 Jul 2014

Lifestyle impacts likelihood of developing metabolic syndrome in childhood cancer survivors

A St. Jude Children's Research Hospital study found that 73 percent of adult survivors of childhood cancer more than doubled their risk of developing metabolic syndrome and related health problems by failing to follow a heart-healthy lifestyle. The results appear in the current issue of the journal Cancer.

28 Jul 2014

Nicotine, cotinine can potentially inhibit DNA damage caused by NNK in tobacco smoke

A new in vitro study has revealed that nicotine and cotinine, a metabolite of nicotine, can potentially inhibit DNA damage caused by a certain carcinogen in smoke.

28 Jul 2014

Researchers provide global genotype prevalence estimates for HCV

In one of the largest prevalence studies to date, researchers from the U.K. provide national, regional, and global genotype prevalence estimates for the hepatitis C virus (HCV). Findings published in Hepatology, a journal of the American Association for the Study of Liver Diseases, indicate that genotype 1 is the most prevalent worldwide, with over 83 million patients infected of which one-third reside in East Asia.

28 Jul 2014

Medical News

Researchers receive grant to improve treatment for patients with COPD

New wave of patients boosting hospital earnings

St. Jude Children's Research Hospital earns Secretary of Defense Employer Support Freedom Award

Childhood obesity linked to early puberty

Endoscopic resection not always best for localized, early-stage esophageal cancer: Study

ECRI Institute PSO selected to provide patient safety data to MCIC Vermont

Medicare turns up heat on fraud investigations

PLXNA4 gene may increase risk of developing Alzheimer's disease

Astute Medical, OCD partner to expand access to new acute kidney injury test

Psychemedics' Q2 revenue increases 12% to $7.7 million

athenahealth expands strategic agreement with Henry Schein

Cardioxyl reports positive results from CXL-1427 Phase I trial for treatment of ADHF

Avidus acquires Truestar Health

Envarsus gets marketing authorization from EC for treatment of kidney and liver transplant patients

FDA clears Lorus' LOR-253 IND application for treatment of hematologic malignancies

New study in recognition of World Hepatitis Day released on Life Sciences Connect

First Edition: July 28, 2014

Lifestyle impacts likelihood of developing metabolic syndrome in childhood cancer survivors

Nicotine, cotinine can potentially inhibit DNA damage caused by NNK in tobacco smoke

Researchers provide global genotype prevalence estimates for HCV

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News